Should You Buy Eli Lilly Stock Now or Wait for a Dip?
Key takeaways
- LLY NVDA Eli Lilly (NYSE: LLY) is back up to $1 trillion in market cap.
- That s because it s now trading at 40 times its trailing earnings, which isn t exactly cheap.
- In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia.
LLY NVDA Eli Lilly (NYSE: LLY) is back up to $1 trillion in market cap. This year, the stock is up a modest 5%, but over five years, its returns are incredibly impressive at over 400%. The healthcare giant has become a huge player in the GLP-1 weight loss market, and investors have been loading up on its shares amid the opportunities in that space.
What may be troubling, however, is its valuation. That s because it s now trading at 40 times its trailing earnings, which isn t exactly cheap. Is Eli Lilly stock still a good buy today, or are you better off waiting for a possible pullback in its price?
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »